Stock EVT EVOTEC SE
Add to a list
To use this feature you must be a member
Log inSign up

All News Evotec SE

Equities

EVT

DE0005664809

Market Closed - Xetra
Other stock markets
 11:38:57 2024-06-10 am EDT 		After market 01:02:21 pm
8.685 EUR -1.64% Intraday chart for Evotec SE 8.68 -0.06%
08:19am EVOTEC : RBC remains its Buy rating ZD
May. 30 Evotec Partners With French Institutions, Company to Research Obesity MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Evotec SE: Results of the Annual General Meeting 2024
EQ
EVOTEC : RBC remains its Buy rating
ZD
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec : Aurobac Therapeutics presents its R&D strategy & pipeline and announces new development program with Boehringer Ingelheim
PU
Evotec : and QIAGEN enter software collaboration for enhanced multi-omics data insights
PU
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec Partners With French Institutions, Company to Research Obesity
MT
Evotec Joins Collaboration to Identify New Therapies for Obesity, Metabolic Diseases
MT
Evotec, Inserm, Lille Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases
CI
Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases
EQ
Evotec : Update of the Declaration of Conformity with the German Corporate Governance Code for the Year 2023 (May 2024) 127.622 KB
PU
Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington's disease
AQ
Evotec Extends Drug Discovery Collaboration With CHDI Foundation for Huntington's Disease
MT
Evotec, CHDI Foundation Extend 20-year Partnership for Huntington's Disease Treatments
MT
Evotec and CHDI Foundation Extend Strategic Drug Discovery Collaboration in Huntington?s Disease
CI
Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease
EQ
Evotec : today announced receipt of a written notice from NASDAQ
PU
Evotec : Additional Information regarding agenda item 5 (Approval of Remuneration Report)
PU
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EVT Stock
  4. News Evotec SE